Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -56.02%-284.42K | -71.24%-237.64K | 54.07%-98.05K | 4.42%-630.88K | 43.60%-96.33K | -11.60%-182.3K | -24.29%-138.77K | 0.37%-213.49K | -30.58%-660.08K | -65.42%-170.8K |
| Net income from continuing operations | -391.61%-794.71K | 66.12%-123.03K | 12.44%-461.42K | -3,260.71%-25.8M | -282,475.31%-24.75M | 58.70%-161.66K | -277.94%-363.14K | -94.12%-526.96K | 40.00%-767.69K | 96.48%-8.76K |
| Operating gains losses | 235.00%127.4K | -665.98%-413.83K | -99.70%428 | 519.54%670.11K | 476.26%550.03K | -183.34%-94.38K | 157.29%73.12K | 16,547.35%141.34K | -147.22%-159.73K | -21,317.13%-146.19K |
| Depreciation and amortization | 14.59%11.3K | 14.58%11.3K | 14.59%11.3K | 14.58%45.18K | 58.33%15.61K | 0.00%9.86K | 0.00%9.86K | 0.00%9.86K | 0.00%39.43K | 0.00%9.86K |
| Asset impairment expenditure | ---- | ---- | ---- | --23.97M | ---- | ---- | ---- | ---- | --0 | ---- |
| Other non cashItems | 271.57%399.78K | 137.50%283.24K | 116.66%322.83K | 14.53%470.14K | -7.87%94.28K | -14.70%107.59K | 31.04%119.26K | 63.75%149K | 13.29%410.48K | -3.26%102.34K |
| Change In working capital | 35.52%-28.19K | -78.82%4.69K | 117.10%28.81K | 104.66%8.5K | 113.13%16.81K | -106.25%-43.72K | 97.71%22.14K | 129.81%13.27K | -636.61%-182.58K | -535.45%-128.05K |
| -Change in receivables | -232.10%-9.08K | -230.17%-7.86K | -1.26%-4.44K | 241.78%12.75K | 143.76%4.21K | 308.71%6.88K | -25.27%6.04K | -5.54%-4.38K | -138.07%-8.99K | -301.04%-9.63K |
| -Change in prepaid assets | 77.95%-3.16K | -49.91%32.76K | -14.09%-31.04K | 166.60%34.68K | 135.19%10.81K | -40.64%-14.33K | 585.08%65.41K | -1,274.57%-27.2K | -1,119.56%-52.06K | -256.90%-30.7K |
| -Change in payables and accrued expense | 56.02%-15.95K | 59.01%-20.21K | 43.32%64.29K | 67.97%-38.92K | 102.04%1.79K | -370.22%-36.26K | -397.04%-49.31K | 205.08%44.86K | -927.60%-121.53K | -816.77%-87.73K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -56.02%-284.42K | -71.24%-237.64K | 54.07%-98.05K | 4.42%-630.88K | 43.60%-96.33K | -11.60%-182.3K | -24.29%-138.77K | 0.37%-213.49K | -30.58%-660.08K | -65.42%-170.8K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -35.15%-8.76K | 66.20%-8.76K | -9.5K | -1.77%-53.82K | 59.51%-21.41K | -6.48K | -25.93K | 0 | -192.66%-52.89K | -52.89K |
| Net PPE purchase and sale | ---- | ---- | ---- | ---2K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net other investing changes | -35.15%-8.76K | ---8.76K | ---9.5K | 2.01%-51.82K | ---19.41K | ---6.48K | ---- | ---- | -192.66%-52.89K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -35.15%-8.76K | 66.20%-8.76K | ---9.5K | -1.77%-53.82K | 59.51%-21.41K | ---6.48K | ---25.93K | --0 | -192.66%-52.89K | ---52.89K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 38.41%262.53K | 113.51%285.59K | -67.17%101.92K | 13.38%801.72K | 20.10%167.83K | 88.64%189.68K | -47.35%133.76K | 45.94%310.45K | 35.21%707.08K | 4.62%139.74K |
| Net issuance payments of debt | 38.41%262.53K | 113.51%285.59K | -67.17%101.92K | 13.38%801.72K | 20.10%167.83K | 88.64%189.68K | -47.35%133.76K | 45.94%310.45K | 35.21%707.08K | 4.62%139.74K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 38.41%262.53K | 113.51%285.59K | -67.17%101.92K | 13.38%801.72K | 20.10%167.83K | 88.64%189.68K | -47.35%133.76K | 45.94%310.45K | 35.21%707.08K | 4.62%139.74K |
| Net cash flow | ||||||||||
| Beginning cash position | 56.45%234.29K | 7.97%195.1K | 139.76%200.73K | -6.57%83.72K | -10.15%150.65K | -35.02%149.75K | 105.20%180.69K | -6.57%83.72K | -0.68%89.61K | 116.73%167.67K |
| Current changes in cash | -3,509.45%-30.65K | 226.64%39.19K | -105.81%-5.63K | 2,088.60%117.01K | 159.67%50.09K | 101.43%899 | -121.73%-30.94K | 6,343.79%96.97K | -855.19%-5.88K | -785.40%-83.94K |
| End cash Position | 35.17%203.63K | 56.45%234.29K | 7.97%195.1K | 139.76%200.73K | 139.76%200.73K | -10.15%150.65K | -35.02%149.75K | 105.20%180.69K | -6.57%83.72K | -6.57%83.72K |
| Free cash from | -56.02%-284.42K | -71.24%-237.64K | 54.07%-98.05K | 2.68%-642.38K | 36.87%-107.83K | -11.60%-182.3K | -24.29%-138.77K | 0.37%-213.49K | -30.58%-660.08K | -65.42%-170.8K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.